Otsuka M, Tokumitsu K, Matsuda Y
Department of Pharmaceutical Technology, Kobe Pharmaceutical University, Motoyama-Kitamachi, Higashi-Nada, 658, Kobe, Japan.
J Control Release. 2000 Jul 3;67(2-3):369-84. doi: 10.1016/s0168-3659(00)00229-7.
A surface-modified silica gel was produced to improve the surface affinity to an oily medicine, phytonadione (VK1). The effect of the degree of surface modification of the silica gel on the drug release behavior from the silica porous matrix was investigated. The silica gels were surface-modified using the silan coupling agent, 3-methacryloxypropyltrimethoxysilane (C7), octadecyltriethoxysilane (C18), or 3,3,3-trifluoropropyltrimethoxysilane (F3). A mixture of VK1 solution and surface-modified silica gel was evaporated under reduced pressure at room temperature, then the resulting powder was dried in vacuo. The degree of surface modification was evaluated based upon elementary analysis. The dissolution profiles of the samples were investigated in Japanese Pharmacopoeia XII, 1st fluid buffer (pH 1.2, 37+/-0.5 degrees C) containing 1.5% sodium lauryl sulfate. The FT-IR spectra of VK1-loaded surface-modified silica gels suggested that the amount of hydrogen-bonded VK1 with the silanol group on the gel surface decreased with increasing hydrophobicity of the silica gel. Since the modified group was rotating on the silica gel surface, and inhibited the adsorption of VK1 to the surface, the attractive molecular interaction between VK1 and the silica gel surface might decrease with increasing length of the modified functional group. However, the characteristics of the affinity of VK1 to the functional groups significantly differed among the groups. The VK1 release from the modified silica gels was initially rapid, slowed markedly after 1 h, and continued for more than 24 h. The amount of VK1 released from the modified surface silica gels by C7, C18 or F3 increased with increasing density of the surface modification group. The mean drug release moment (MDT) decreased with an increase in surface-modified group density.
制备了一种表面改性硅胶,以提高其对油性药物维生素K1(VK1)的表面亲和力。研究了硅胶表面改性程度对药物从硅胶多孔基质中释放行为的影响。使用硅烷偶联剂3-甲基丙烯酰氧基丙基三甲氧基硅烷(C7)、十八烷基三乙氧基硅烷(C18)或3,3,3-三氟丙基三甲氧基硅烷(F3)对硅胶进行表面改性。将VK1溶液与表面改性硅胶的混合物在室温下减压蒸发,然后将所得粉末真空干燥。基于元素分析评估表面改性程度。在日本药典 XII的含有1.5%十二烷基硫酸钠的第一液缓冲液(pH 1.2,37±0.5℃)中研究样品的溶出曲线。负载VK1的表面改性硅胶的FT-IR光谱表明,随着硅胶疏水性的增加,与凝胶表面硅醇基团形成氢键的VK1量减少。由于改性基团在硅胶表面旋转,并抑制了VK1对表面的吸附,VK1与硅胶表面之间有吸引力的分子相互作用可能会随着改性官能团长度的增加而降低。然而,各组中VK1对官能团的亲和力特征存在显著差异。VK1从改性硅胶中的释放最初很快,1小时后明显减慢,并持续超过24小时。C7、C18或F3改性表面硅胶释放的VK1量随着表面改性基团密度的增加而增加。平均药物释放时刻(MDT)随着表面改性基团密度的增加而降低。